文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

玻璃体内注射重组组织型纤溶酶原激活剂及气体置换治疗黄斑下视网膜出血：病例系列

Intravitreal r-tPA Injection and Pneumatic Displacement for Submacular Retinal Hemorrhage: A Case Series.

作者信息

Confalonieri Filippo, Stene-Johansen Ingar, Lumi Xhevat, Petrovski Goran

机构信息

Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.

Center for Eye Research, Department of Ophthalmology, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

出版信息

Case Rep Ophthalmol. 2022 Aug 16;13(2):630-637. doi: 10.1159/000526068. eCollection 2022 May-Aug.

DOI:10.1159/000526068

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9459647/

Abstract

We describe the results of very early pars plana vitrectomy, subretinal r-tPA, and gas tamponade in patients with subretinal macular hemorrhage secondary to neovascular age-related macular degeneration. The patients ended up with a favorable functional recovery. We conclude that very early treatment might lead to a good functional prognosis.

摘要

我们描述了对继发于新生血管性年龄相关性黄斑变性的黄斑下出血患者进行极早期玻璃体切除术、视网膜下注射重组组织型纤溶酶原激活剂（r-tPA）及气体填塞的结果。患者最终获得了良好的功能恢复。我们得出结论，极早期治疗可能会带来良好的功能预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/7f2414df371a/cop-0013-0630-g06.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/18b2948c1645/cop-0013-0630-g01.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/1eb72d66956f/cop-0013-0630-g02.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/813cac4d61a3/cop-0013-0630-g03.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/6509d07e12cd/cop-0013-0630-g04.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/0ba9b657b7e0/cop-0013-0630-g05.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/7f2414df371a/cop-0013-0630-g06.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/18b2948c1645/cop-0013-0630-g01.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/1eb72d66956f/cop-0013-0630-g02.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/813cac4d61a3/cop-0013-0630-g03.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/6509d07e12cd/cop-0013-0630-g04.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/0ba9b657b7e0/cop-0013-0630-g05.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17f/9459647/7f2414df371a/cop-0013-0630-g06.jpg

相似文献

1

Intravitreal r-tPA Injection and Pneumatic Displacement for Submacular Retinal Hemorrhage: A Case Series.玻璃体内注射重组组织型纤溶酶原激活剂及气体置换治疗黄斑下视网膜出血：病例系列

Case Rep Ophthalmol. 2022 Aug 16;13(2):630-637. doi: 10.1159/000526068. eCollection 2022 May-Aug.

2

Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab.采用玻璃体切除术、黄斑下注射组织型纤溶酶原激活剂（tPA）继以玻璃体内注射雷珠单抗治疗年龄相关性黄斑变性相关的黄斑下出血移位

Clin Ophthalmol. 2010 Jul 21;4:637-42. doi: 10.2147/opth.s10060.

3

Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.年龄相关性黄斑变性所致黄斑下出血不同治疗技术的比较。

Eur J Ophthalmol. 2021 Sep;31(5):2621-2624. doi: 10.1177/1120672120959551. Epub 2020 Sep 29.

4

[Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases].玻璃体切除术、视网膜下注射重组组织型纤溶酶原激活剂、玻璃体内注射贝伐单抗联合气体填充治疗湿性年龄相关性黄斑变性并发黄斑血肿：4例报告

J Fr Ophtalmol. 2017 Feb;40(2):133-137. doi: 10.1016/j.jfo.2016.07.020. Epub 2017 Feb 9.

5

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.玻璃体切除术、视网膜下组织纤维蛋白溶酶原激活物和眼内气体治疗渗出性年龄相关性黄斑变性继发的黄斑下出血（TIGER）：一项 3 期、泛欧、2 组、非商业、活性对照、观察者设盲、优效性、随机对照手术试验的研究方案。

Trials. 2022 Jan 31;23(1):99. doi: 10.1186/s13063-021-05966-3.

6

Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration.年龄相关性黄斑变性中应用组织型纤溶酶原激活物和气动移位治疗黄斑下出血。

Eur J Ophthalmol. 2021 Mar;31(2):643-648. doi: 10.1177/1120672119891625. Epub 2019 Dec 9.

7

TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.组织型纤溶酶原激活剂治疗年龄相关性黄斑变性所致黄斑下出血：三种治疗方式的比较

Retina. 2016 Oct;36(10):1860-5. doi: 10.1097/IAE.0000000000001030.

8

Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.玻璃体切除术治疗黄斑变性引起的黄斑下出血：黄斑下出血/膜去除术与黄斑下组织纤溶酶原激活剂辅助气体置换术的比较

Trans Am Ophthalmol Soc. 2005;103:98-107; discussion 107.

9

Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.黄斑下出血的气体置换联合视网膜下空气及组织型纤溶酶原激活剂：美国的初步经验

Ophthalmol Retina. 2018 Mar;2(3):180-186. doi: 10.1016/j.oret.2017.07.012. Epub 2017 Sep 28.

10

Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.应用组织型纤溶酶原激活物(subretinal tissue plasminogen activator, srt-PA)和空气动力学移位(subretinal tissue plasminogen activator, srt-PA)治疗年龄相关性黄斑变性的厚型脉络膜下出血的管理。

Am J Ophthalmol. 2014 Jun;157(6):1250-7. doi: 10.1016/j.ajo.2014.02.007. Epub 2014 Feb 13.

引用本文的文献

1

Outcomes in the Treatment of Subretinal Macular Hemorrhage Secondary to Age-Related Macular Degeneration: A Systematic Review.年龄相关性黄斑变性继发视网膜下黄斑出血的治疗结局：一项系统评价

J Clin Med. 2024 Jan 9;13(2):367. doi: 10.3390/jcm13020367.

本文引用的文献

1

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.玻璃体切除术、视网膜下组织纤维蛋白溶酶原激活物和眼内气体治疗渗出性年龄相关性黄斑变性继发的黄斑下出血（TIGER）：一项 3 期、泛欧、2 组、非商业、活性对照、观察者设盲、优效性、随机对照手术试验的研究方案。

Trials. 2022 Jan 31;23(1):99. doi: 10.1186/s13063-021-05966-3.

2

Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm.玻璃体切割术联合视网膜下注射组织型纤溶酶原激活剂治疗年龄相关性黄斑变性或大动脉瘤继发黄斑下出血后的视力预后

J Ophthalmol. 2021 Dec 30;2021:3160963. doi: 10.1155/2021/3160963. eCollection 2021.

3

Macular Hemorrhage Due to Age-Related Macular Degeneration or Retinal Arterial Macroaneurysm: Predictive Factors of Surgical Outcome.年龄相关性黄斑变性或视网膜动脉大动脉瘤所致黄斑出血：手术结果的预测因素

J Clin Med. 2021 Dec 10;10(24):5787. doi: 10.3390/jcm10245787.

4

Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade to Displace Acute Submacular Haemorrhages Secondary to Age-Related Macular Degeneration.视网膜下注射重组组织型纤溶酶原激活剂联合气体填塞治疗年龄相关性黄斑变性继发急性黄斑下出血

Clin Ophthalmol. 2021 Aug 28;15:3649-3659. doi: 10.2147/OPTH.S324091. eCollection 2021.

5

Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.比较重组组织型纤溶酶原激活剂与气体经视网膜下和玻璃体内注射治疗湿性年龄相关性黄斑变性继发的黄斑下出血：治疗结果和简要文献复习。

Int Ophthalmol. 2021 Dec;41(12):4037-4046. doi: 10.1007/s10792-021-01976-x. Epub 2021 Jul 30.

6

Age-related macular degeneration.年龄相关性黄斑变性。

Nat Rev Dis Primers. 2021 May 6;7(1):31. doi: 10.1038/s41572-021-00265-2.

7

Management of acute submacular hemorrhage using intravitreal injection of tissue plasminogen activator and gas: A case series.玻璃体内注射组织型纤溶酶原激活剂和气体治疗急性黄斑下出血：病例系列

SAGE Open Med Case Rep. 2020 Nov 13;8:2050313X20970337. doi: 10.1177/2050313X20970337. eCollection 2020.

8

Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.年龄相关性黄斑变性所致黄斑下出血不同治疗技术的比较。

Eur J Ophthalmol. 2021 Sep;31(5):2621-2624. doi: 10.1177/1120672120959551. Epub 2020 Sep 29.

9

Antioxidants Mediate Both Iron Homeostasis and Oxidative Stress.抗氧化剂介导铁稳态和氧化应激。

Nutrients. 2017 Jun 28;9(7):671. doi: 10.3390/nu9070671.

10

PNEUMATIC DISPLACEMENT OF LIMITED TRAUMATIC SUBMACULAR HEMORRHAGE WITHOUT TISSUE PLASMINOGEN ACTIVATOR: A CASE SERIES.不使用组织型纤溶酶原激活剂的有限创伤性黄斑下出血的气动移位：病例系列

Retin Cases Brief Rep. 2019;13(1):34-38. doi: 10.1097/ICB.0000000000000525.